Lægemiddelkombination og dets anvendelse til behandling af muskeltab

摘要

The present invention is a product comprising a beta2 agonist and a progestin, as a combined preparation for separate, simultaneous or sequential use in the treatment or prevention of muscle loss. The present invention is also a beta2 agonist selected from R,R-formoterol, indacaterol or ritodrine, for use in the treatment or prevention of muscle loss.